China group buys into True Group; IPO on cards
US$36.7m investment in Singapore-based fitness operator paves way for expansion across China
Singapore
HONG Kong-listed Tongfang Kontafarma has acquired a sizeable stake in Singapore-based fitness and wellness provider True Group for US$36.7 million in cash, a move that paves the way for the latter to significantly expand its presence across China.
The deal, announced on Tuesday afternoon, will see Tongfang Kontafarma - a Chinese company indirectly invested by Tsinghua University that primarily manufactures and sells prescription drugs - take a 51 per cent stake in True's Singapore and China businesses, as well as a 29 per cent stake in its Taiwan operations.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Struggling French tech group Atos weighs financial lifelines
Brokers’ take: DBS cuts Venture Corp price target after Q1 earnings miss
GLP says 2025 bond repayment sources identified
Volvo Cars April sales rise on strong EV demand
KKR to buy India's Healthium Medtech at US$839 million valuation
Adani in talks with banks to borrow US$600 million for gas unit